Literature DB >> 21521336

Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences.

A Pal1, C Capatina, A P Tenreiro, P D Guardiola, J V Byrne, S Cudlip, N Karavitaki, J A H Wass.   

Abstract

OBJECTIVES: The frequency of pituitary tumour regrowth after an episode of classical pituitary apoplexy is unknown. It is thus unclear whether regrowth, if it occurs, does so less frequently than with non-apoplectic non-functioning pituitary macroadenomas that have undergone surgery without postoperative irradiation. This has important repercussions on follow up protocols for these patients.
DESIGN: Retrospective cohort study of patients diagnosed with classical pituitary apoplexy in Oxford in the last 24 years. MEASUREMENTS: MRI/CT scans of the pituitary were performed post-operatively and in those patients who did not receive pituitary irradiation, this was repeated yearly for 5 years and 2 yearly thereafter.
RESULTS: Thirty-two patients with non-functioning pituitary adenomas who presented with classical pituitary apoplexy were studied. There were 23 men and the mean age was 56·6 years (range 29-85). The mean follow up period was 81 months (range 6-248). Five patients received adjuvant radiotherapy within 6 months of surgery and were excluded from further analysis. In this group, there were no recurrences during a mean follow up of 83 months (range 20-150). In the remaining 27 cases there were 3 recurrences, with a mean of 79 months follow up (range 6-248) occurring 12, 51 and 86 months after surgery. This gives a recurrence rate of 11·1% at a mean follow up of 6·6 years post surgery. All recurrences had residual tumour on the post operative scan.
CONCLUSIONS: Patients with classical pituitary apoplexy may show recurrent pituitary tumour growth and therefore these patients need continued post-operative surveillance if they have not had post-operative radiotherapy.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21521336     DOI: 10.1111/j.1365-2265.2011.04068.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Pituitary apoplexy.

Authors:  Wenya Linda Bi; Ian F Dunn; Edward R Laws
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

2.  Delayed Diagnosis of Cushing's Disease in a Pediatric Patient due to Apparent Remission from Spontaneous Apoplexy.

Authors:  Sara H Rahman; Prashant Chittibonia; Martha Quezado; Nicholas Patronas; Constantine A Stratakis; Maya B Lodish
Journal:  J Clin Transl Endocrinol Case Rep       Date:  2016-12

3.  Visual and Hormone Outcomes in Pituitary Apoplexy: Results of a Single Surgeon, Single Institution 15-Year Retrospective Review and Pooled Data Analysis.

Authors:  Scott C Seaman; Mark C Dougherty; Mario Zanaty; Leslie A Bruch; Scott M Graham; Jeremy D W Greenlee
Journal:  J Neurol Surg B Skull Base       Date:  2020-06-19

4.  Predictive Clinical and Surgical Factors Associated with Recurrent Apoplexy in Pituitary Adenomas.

Authors:  Alan Siu; Sanjeet Rangarajan; Michael Karsy; Christopher J Farrell; Gurston Nyquist; Marc Rosen; James J Evans
Journal:  J Neurol Surg B Skull Base       Date:  2021-09-10

Review 5.  Apoplexy in nonfunctioning pituitary adenomas.

Authors:  Luiz Eduardo Wildemberg; Andrea Glezer; Marcello D Bronstein; Mônica R Gadelha
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

6.  Recurrent pituitary apoplexy due to two successive neoplasms presenting with ocular paresis and epistaxis.

Authors:  Stephanie Teasdale; Fahid Hashem; Sarah Olson; Benjamin Ong; Warrick J Inder
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-02-01

7.  Pituitary Apoplexy After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitor: A Novel Complication.

Authors:  Rebecca A Kasl; Heather M Kistka; Justin H Turner; Jessica K Devin; Lola B Chambless
Journal:  J Neurol Surg Rep       Date:  2015-08-24

Review 8.  Multidisciplinary Management of Pituitary Apoplexy.

Authors:  Adriana Albani; Francesco Ferraù; Filippo Flavio Angileri; Felice Esposito; Francesca Granata; Felicia Ferreri; Salvatore Cannavò
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

9.  Ischemic Infarction of Pituitary Apoplexy: A Retrospective Study of 46 Cases From a Single Tertiary Center.

Authors:  Qiang Zhu; Yuchao Liang; Ziwen Fan; Yukun Liu; Chunyao Zhou; Hong Zhang; Tianshi Li; Yanpeng Zhou; Jianing Yang; Yinyan Wang; Lei Wang
Journal:  Front Neurosci       Date:  2022-01-24       Impact factor: 4.677

10.  Neurological Presentation of Giant Pituitary Tumour Apoplexy: Case Report and Literature Review of a Rare but Life-Threatening Condition.

Authors:  Valentina Puglisi; Elisabetta Morini; Fiammetta Biasini; Luisa Vinciguerra; Giuseppe Lanza; Placido Bramanti
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.